Navigation Links
Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
Date:5/15/2009

STOCKHOLM, Sweden, May 15 /PRNewswire-USNewswire/ -- The Karolinska Institutet in Stockholm today awarded an honorary post-doctoral degree to Kevin J. Tracey, MD, director and chief executive officer of The Feinstein Institute for Medical Research in Manhasset, NY.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090515/DC17878)

Dr. Tracey, a neurosurgeon whose work has helped unravel how the brain communicates with the immune system, joins a long and distinguished list of scientists who have received this honor from the Karolinska Institutet, including Nobel Prize winners Paul Greengard, PhD, and Torsten Weisel, PhD, both at Rockefeller University in Manhattan.

Each year, the Karolinska Institutet awards three honorary degrees to scientists selected by the Karolinska's Board of Research. Others honored today by the Karolinska at Stockholm City Hall were Hakan Mogren, one of Sweden's most prominent figures within trade and industry, and Ulla Fohrer, a speech therapist and researcher at Karolinska Institutet. The three honorees received their doctoral hats, diplomas and rings from the Dean of Research as confirmation of their new status.

Dr. Tracey's discoveries have paved the way for the development of new medicines to treat chronic rheumatoid arthritis, inflammatory bowel disease and infection. He has made considerable contributions towards improving knowledge of regulating inflammatory processes.

The Karolinska Institutet is one of the leading medical universities in Europe. Through research and education, the Karolinska Institutet contributes to improving human health. Each year, the Nobel Assembly at the Karolinska Institutet awards the Nobel Prize in Physiology or Medicine.

In 2008, the Karolinska Institutet and the Feinstein Institute signed a collaborative agreement that paves the way for Karolinska graduates to conduct post-doctoral research in New York and scientists from the Feinstein to study at the Karolinska's laboratories in Stockholm.

About The Feinstein Institute for Medical Research: Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in cancer, leukemia, lymphoma, Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, diabetes, human genetics, neuroimmunology, and medicinal chemistry. Feinstein researchers are developing new drugs and drug targets, and producing results where science meets the patient, annually enrolling some 10,000 subjects into clinical research programs.


'/>"/>
SOURCE The Feinstein Institute for Medical Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Development Invests in EvoStem Finland Oy
2. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. 3 new honorary doctors at Karolinska Institutet
5. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
6. YWCA USA 2009 Hallmark Initiative Awards Presented to YWCA Central Massachusetts and YWCA Niagara
7. Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression Community
8. SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards
9. ScienceFirst Receives ADCNJ Awards
10. ADA Foundation Hosts Second Give Kids A Smile Awards Gala
11. HealthWorldNet.com Announces HealthWiNs Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important webinar ... at 1:00 PM ET. A recording of the webinar will also be made available ... Home health and hospice companies are still popular targets for healthcare investors. This highly ...
(Date:3/29/2017)... North Hollywood, CA (PRWEB) , ... March 29, 2017 , ... ... and Northridge , is now offering laser dental treatments. Dental lasers are safe ... treatments. Laser dentistry expands patients’ options and can improve the overall quality of care. ...
(Date:3/29/2017)... , ... March 29, 2017 , ... The Wharton School ... and Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education ... quality, the field must first improve teacher preparation program design. It then asserts ... and that decades of input- and outcome-based research has failed to improve teacher ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... first technology to directly address the resolution to globally reduce the harmful use ... patented compound of FDA and TTB approved ingredients that when infused into alcohol, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... AMSTERDAM , March 29, 2017   ... global leader in health technology, and PathAI, a ... are collaborating with the aim to develop solutions ... diagnosis of cancer and other diseases. The partnership ... pathology, enabling this form of artificial intelligence to ...
(Date:3/29/2017)... Michigan , USA, March 29, 2017 ... Company that Cares by People magazine, in partnership with ... of 50 companies on the list. This list highlights ... that have succeeded in business while also demonstrating respect, ... the environment.  To determine the companies ...
(Date:3/29/2017)... , March 29, 2017 On March 28, the ... treat adult patients with relapsing forms of multiple sclerosis ... the first drug approved by the FDA for PPMS. ... care professional.  "Multiple sclerosis can have ... Billy Dunn , M.D., director of the Division of ...
Breaking Medicine Technology: